BioCentury
ARTICLE | Financial News

Ra raises $50.4M in follow-on

February 23, 2018 8:25 PM UTC

Complement-mediated disease company Ra Pharmaceuticals Inc. (NASDAQ:RARX) raised $50.4 million on Feb. 14 through the sale of 8.4 million shares at $6 in a follow-on underwritten by Credit Suisse, Jefferies, BMO Capital Markets and SunTrust Robinson Humphrey...

BCIQ Company Profiles

Ra Pharmaceuticals Inc.